There is no dedicated pediatric chamber class in the US. Pediatric HBOT for FDA uses happens in standard hospital chambers. Most are Sechrist 3300 and Perry Sigma lines with pediatric protocol changes.
This guide treats the category honestly. The chamber market is small and the uses are narrow. The marketing gap is the largest in pediatric HBOT.
What pediatric HBOT actually looks like
In hospital programs, the child is treated in a standard monoplace chamber. Sedation is used as needed. Sessions match adult HBOT — 2.0 to 3.0 ATA for 90 to 120 minutes. See complete FDA-cleared chambers list for the complete chamber-by-chamber list.
Pediatric protocols differ on:
- Sedation requirements based on age and temperament
- Session frequency adapted to school schedule and family needs
- Parent presence and chamber communication
- Pre-session and post-session pediatric assessment
The chambers are not pediatric-specific. The openFDA 510(k) database (2024) lists 69 cleared chambers under product code CBF. None are exclusively pediatric.
FDA-approved pediatric indications
The 14 FDA-approved HBOT uses listed by Medicare (2024) include several that apply to children:
- Carbon monoxide poisoning
- Crush injury and acute traumatic ischemia
- Gas gangrene and clostridial infection
- Decompression sickness (in older children who dive)
- Refractory osteomyelitis
- Necrotizing soft-tissue infection
- Severe anemia
- Cyanide poisoning
- Selected severe burns
For these uses, pediatric HBOT runs at academic centers and major children's hospitals. UCSF, Boston Children's, CHOP, Cincinnati Children's, Texas Children's, and other centers run HBOT programs.
Major pediatric HBOT programs
| Program | City | Chamber type | Notes |
|---|---|---|---|
| UCSF Children's | San Francisco, CA | Hard-shell monoplace | Pediatric HBOT for FDA indications |
| Boston Children's | Boston, MA | Hard-shell monoplace | One of the longest-running US programs |
| Children's Hospital of Philadelphia | Philadelphia, PA | Hard-shell monoplace | Strong neurology referrals |
| Cincinnati Children's | Cincinnati, OH | Hard-shell monoplace | Major Midwest pediatric center |
| Texas Children's | Houston, TX | Hard-shell monoplace | Largest US children's hospital |
| Children's Hospital Colorado | Aurora, CO | Hard-shell monoplace | Mountain altitude considerations |
UHMS accreditation status for pediatric programs varies. 180 of the 1,588 US HBOT centers in our directory hold UHMS accreditation (2024).
Several major pediatric programs are accredited. Others run under their parent hospital's accreditation.
For specific accreditation status, check the UHMS facility directory (2024).
The pediatric off-label problem
The honest part: off-label use is heavily marketed.
Common off-label uses at wellness clinics include autism, ADHD, cerebral palsy, and TBI. The FDA consumer warning (2021) is direct: none of these are FDA-approved. See the cerebral palsy evidence atlas for the full investigational evidence breakdown.
The marketing pattern is consistent across off-label pediatric HBOT clinics:
- Clinical-sounding language for soft-shell 1.3 ATA sessions
- Testimonials and parent stories instead of controlled-trial evidence
- Multi-session packages sold at significant cost
- Pressure to commit before medical evaluation
Our HBOT for ADHD evidence review (2026) covers the data. Controlled-trial results do not support HBOT for ADHD.
What the evidence actually says about pediatric off-label HBOT
For pediatric autism, multiple controlled trials at hyperbaric pressures showed no clear effect. The Cochrane review on HBOT in cerebral palsy (2014) found no clear benefit.
For pediatric TBI and concussion, evidence at adult-grade pressures is mixed. Mild HBOT at 1.3 ATA has the weakest evidence base.
For autism, controlled trial data has not supported routine HBOT use. The American Academy of Pediatrics has not endorsed HBOT for autism.
The framing is consistent. Pediatric off-label HBOT is investigational at best. See our institutional silence on HBOT (2026) for the broader landscape.
What parents should ask before booking pediatric HBOT
Six questions for any pediatric HBOT program.
- What is the doctor's pediatric and hyperbaric training?
- What is the evidence for HBOT in our child's use case?
- What is the chamber's FDA 510(k) clearance and pressure?
- What is the planned protocol — pressure, duration, session count?
- What is the safety briefing for pediatric patients?
- What is the complication response plan?
For FDA uses at academic centers, the answers are clear. For off-label use at wellness clinics, the answers are often less clear.
The honest reality. Legit pediatric HBOT for FDA uses is rare in elective settings. Most pediatric HBOT inquiries lead to wellness clinics offering off-label sessions.
Cost considerations
Hospital-grade pediatric HBOT at academic centers is insurance-billed for FDA-approved uses. Cash prices run $400 to $700 per session.
Wellness clinic pediatric HBOT (typically 1.3 ATA soft-shell) is cash-pay. Per-session prices run $150 to $300. Multi-session packages of 40 sessions can total $6,000 to $12,000.
The cost-benefit at the wellness end is hard to justify given limited evidence at the pressures used.
Where to draw the line
Hospital pediatric HBOT for FDA-approved uses is legitimate medicine. It happens in the right facilities with insurance coverage.
Wellness clinic pediatric HBOT for off-label developmental conditions is investigational at best. Evidence at the pressures used is limited. Parents should consult pediatric neurology or family medicine before committing.
The line isn't whether HBOT can be used in children. It can, for the right uses. The line is whether the specific use has published evidence and whether the program is properly supervised.
Related reading
- HBOT for ADHD: what the evidence actually shows
- Institutional silence on HBOT
- HBOT clinic red flags: signs of unsafe practice
- Questions to ask before booking an HBOT clinic
Frequently asked questions
Is there a special chamber for pediatric patients?
No dedicated pediatric chamber class exists in the US market. Pediatric HBOT happens in standard hospital monoplace chambers — typically a Sechrist 3300 or Perry Sigma — with protocol adapts including sedation, parent presence, and school schedule planning.
Does insurance cover pediatric HBOT?
For the 14 FDA-approved indications when delivered at a UHMS-accredited or equivalent pediatric facility, yes. Coverage requires medical necessity documentation. Off-label pediatric uses at wellness clinics are not covered by insurance.
What about HBOT for autism or ADHD in children?
Controlled-trial evidence does not support HBOT as a treatment for autism or ADHD in children. Both conditions are commonly marketed targets at off-label pediatric HBOT clinics. The American Academy of Pediatrics has not endorsed HBOT for these uses. See our HBOT for ADHD evidence review for the detailed evidence breakdown.
Is HBOT safe for children?
For FDA-approved uses at academic centers, pediatric HBOT has the same safety profile as adult HBOT. Ear barotrauma at 2 to 10%, oxygen toxicity at 1 to 2%, fire risk the facility manages. Off-label use with limited evidence shifts the risk-benefit.
What is the best pediatric HBOT program in the US?
For FDA-approved indications, the major children's hospitals listed above all deliver appropriate care. Choice between them depends on geographic proximity, in-network insurance status, and the specific indication. For off-label uses, the question is whether the indication has evidence and whether the program is supervised by qualified pediatric and hyperbaric clinicians.
Medical disclaimer
This article is for informational purposes only and is not medical advice. Pediatric HBOT for FDA-approved uses runs at academic medical centers. Off-label uses are investigational with limited evidence at the pressures used. Consult your pediatrician before pursuing pediatric HBOT.
-- The HBOT Finder Team